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Objective: To determine whether single nucleotide polymorphisms (SNPs) of the
cholinergic system and quantitative parameters of postural control are associated in
healthy older adults. This is a cross-sectional analysis from the TREND study.
Methods: All participants performed a static postural control task for 30 s on a foam
pad in semitandem stance and eyes closed. We analyzed mean power frequency
(MPF), area, acceleration, jerk, and velocity from a mobile sensor worn at the lower
back using a validated algorithm. Genotypes of four SNPs in genes involved in the
cholinergic system (SLC5A7, CHAT, BCHE, CHRNA4) were extracted from the NeuroX
chip. All participants present a normal neurological examination and a Minimental state
examination score >24.
Results: Four hundred and seventy seven participants were included. Mean age was
69 years, 41% were female. One SNP of the cholinergic pathway was significantly
associated with a quantitative postural control parameter. The minor allele of rs6542746
in SLC5A7 was associated with lower MPF (4.04 vs. 4.22 Hz; p = 3.91 × 10−4).
Moreover, the following associations showed trends toward significance: minor allele
of rs6542746 in SLC5A7 with higher anteroposterior acceleration (318 vs. 287 mG;
p = 0.005), and minor allele of rs3810950 in CHAT with higher mediolateral acceleration
[1.77 vs. 1.65 log(mG); p = 0.03] and velocity [1.83 vs. 1.74 log(mm/s); p = 0.019].
Intraindividual occurrence of rs6542746 and rs3810950 minor alleles was dose-
dependently related with lower MPF (p = 0.004).
Conclusion: This observational study suggests an influence of SNPs of the cholinergic
pathway on postural control in older adults.
Keywords: acetylcholine, balance control, genetic markers, neurodegeneration, single nucleotide polymorphisms
(SNPs)
INTRODUCTION
Postural instability is a common and disabling feature of older adults. One in three adults aged
65 and older will fall at least once a year (Frenklach et al., 2009). Falls result frequently in injuries
such as fractures, and lead to fear of future falls accompanied by decreased mobility and decreased
quality of life (Adkin et al., 2003; Michalowska et al., 2005). Thus, postural instability and falls
represent a serious health problem (Tinetti and Williams, 1997; Manckoundia et al., 2008).
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A fall is most often a consequence of a postural control error,
and repeated occurrence of falls indicate a postural control deficit.
In recent years, evidence has become consistent that degeneration
of cholinergic neurons in the pedunculopontine nucleus (PPN)
-one of the three main sources of acetylcholine supply in the
brain- plays a central role in impaired postural control (Lee
et al., 2000; Bohnen et al., 2009; Kucinski and Sarter, 2015). The
cholinergic pars compacta of the PPN supplies the majority of
cholinergic input to the thalamus and has reciprocal connections
with the basal ganglia nuclei, particularly the substantia nigra
pars compacta, globus pallidus and subthalamic nucleus (Lee
et al., 2000; Pahapill and Lozano, 2000; Yarnall et al., 2011).
Supporting the cholinergic relevance in postural control, several
studies (Bohnen et al., 2009; Karachi et al., 2010; Rochester
et al., 2012; Muller et al., 2013) indicate that degeneration of
the cholinergic part of the PPN plays a central role in impaired
postural control and gait dysfunction in Parkinson disease (PD)
and other degenerative diseases. Moreover, studies demonstrated
improvement in falls rate and postural control parameters by
treatment with anticholinesterase inhibitors (Chung et al., 2010;
Henderson et al., 2016). Interestingly, we did not find data about
degeneration of this system in association with age and postural
control in the “healthy” older population.
The cholinergic system is complex and comprises various
enzymes, transporters, and receptors that interact with, or release
the neurotransmitter acetylcholine during the propagation of a
nerve impulse. Some single nucleotide polymorphisms (SNPs)
of genes from this cholinergic system have been suggested to
have an influence on the occurrence of specific neurodegenerative
diseases (Ozturk et al., 2006). Examples are SNPs in the
sodium ion- and chloride ion-dependent choline transporter
(SLC5A7) rs6542746, the choline O-acetyltransferase (CHAT)
rs3810950, the butyrylcholinesterase (BCHE) rs1803274 gene and
the cholinergic receptor nicotinic alpha 4 subunit (CHRNA4)
rs2236196. SLC5A7 is the gene encoding choline transporter
(ChT). The high-affinity ChT plays an essential role in the control
of ACh synthesis. A specific impairment in cognitive control
associated with a variant of SLC5A7 has been reported (Berry
et al., 2014). However, functional consequences of the analyzed
variant are not yet investigated. CHAT is the gene encoding
choline acetyltransferase (ChAT), the key enzyme responsible
for the synthesis of the neurotransmitter acetylcholine. ChAT
activity decreases in the brains of patients with PD (Ruberg
et al., 1982; Lange et al., 1993), a disease closely associated
with postural control deficits. The AA genotype of the analyzed
SNP was associated with increased risk for AD and the
A allele was hypothesized to increase translation of ChAT
(Kim et al., 2004). Definite functional consequences were not
investigated. The BCHE gene encodes butyrylcholinesterase. The
SNP rs1803274 is the so-called BCHE K-variant (T allele) that
has been reported to lead to reduced hydrolytic activity of
the gene product (Podoly et al., 2009). The mechanism of
action is a prolonged maintenance of acetylcholine (Ach) at the
synaptic cleft due to an increase in concentration. CHRNA4
is the gene encoding the cholinergic receptor nicotinic alpha
4 subunit in nicotinic α4β2 receptors (Yarnall et al., 2011).
SNP variation seems associated with various cognitive and
behavioral changes including schizophrenia (Reinvang et al.,
2010; Greenwood et al., 2012; Eggert et al., 2015) although
a recent meta-analysis does not support a highly relevant
role of this SNP in schizophrenia (Schizophrenia Working
Group of the Psychiatric Genomics Consortium, 2014). Recent
research has shown that a variation in CHRNA4 affects
attentional networks of the brain (Reinvang et al., 2009) and
negative emotionality in normal adults (Tsai et al., 2012).
Functional consequences of the analyzed variant are not yet
investigated.
Static postural control is a central feature of our postural
control system (Maetzler et al., 2013b), and the decline of
this ability during the process of aging has repeatedly been
demonstrated (Berg et al., 1992; Woollacott, 2000; Van Ooteghem
et al., 2009). Generally, the basic assumption in postural control
patterns is that more sway is associated with worse postural
control (Maetzler et al., 2013a). Deficits in postural control can
be identified by wearable sensors, which can detect even subtle
changes of sway patterns (Mancini et al., 2012b; Maetzler et al.,
2013a). The following parameters are often used to describe
this pattern (Rocchi et al., 2004; Maetzler et al., 2012): mean
power frequency (MPF), area, acceleration, jerk and velocity
(Mancini et al., 2012a,b; Park et al., 2016). These parameters
can vary with age and neurodegeneration. For example, MPF
has been shown to be higher in older adults (age >65) when
compared to young adults (age <30) (Demura and Kitabayashi,
2006; Dewhurst et al., 2007) and to be lower in clinical and even
prodromal PD (Mancini et al., 2012a; Hasmann, 2015). Area has
been shown to be larger in PD patients when compared with
controls (Oude Nijhuis et al., 2014), and acceleration to be larger
in older adults than in young adults (Era et al., 2006; Masani et al.,
2007). An increase of jerk has been associated with disturbance
of postural control in neurodegenerative disorders such as PD
(McVey et al., 2009; Mancini et al., 2011, 2012a). Sway velocity
has been associated with age (Era et al., 2006), as well as with
cognitive impairment in older adults (Deschamps et al., 2014)
and PD (Sciadas et al., 2016).
This work aims to discover potential associations between
SNPs of the cholinergic system and quantitative parameters of
postural control in a large cohort of healthy older adults. This
aim is based on the idea that genetically defined differences in the
performance of postural control may serve as a not yet considered
risk factor for postural control deficits and consecutive falls in
vulnerable cohorts.
MATERIALS AND METHODS
Study Participants
We investigated a cohort of 477 healthy older adults, aged
56–88 years. All individuals were evaluated between 2011 and
2012 during the second assessment of the TREND study1.
A detailed description of the study cohort has been provided
previously (Hobert et al., 2011). The study was approved by
the ethical board of the Medical Faculty of the University
1http://www.trend-studie.de
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of Tübingen (No. 90/2009BO2) and all participants provided
written informed consent. Inclusion criteria for the actual
analysis were normal neurological examination, Minimental state
examination >24, and the ability to perform a challenging
postural control task without risk of falling. Exclusion criteria
were more than one of the PD risk factors, REM Sleep
Behaviour Disorder (RBD), hyposmia and depression, and
presence of common LRRK2 or GBA mutations (G2019S
rs34637584, N370S rs76763715, and L444P rs421016) (Healy
et al., 2008). Pallesthesia was assessed with a Rydel-Seiffer
128 Hz tuning fork (median of vibration sensitivity values on
both malleoli mediales). Diagnosis of RBD was based on the
RBD Screening Questionnaire, using a cut-off value of five
points (Richter et al., 2014). The diagnosis of hyposmia was
based on Sniffin’ Sticks. It is a validated and commonly used
tool for the assessment of olfactory function (Lotfipour et al.,
2011). Depression was defined as Beck Depression Inventory
value ≥14 (Ellis et al., 2009). Since the origin of all included
participants is within Europe, we do not expect population
differences.
Assessment and Evaluation of Static
Postural Control
We used a challenging standing task to assess postural control.
Participants were asked to stand for 30 s upright in a close
semitandem stance with eyes closed on a foam pad (Airex balance
pad, 50 cm × 41 cm × 6 cm), with a maximum distance of 5 cm
between the right big toe and the left heel (Figure 1). In case this
position was too difficult to be kept during a 10 s training period,
the participant was allowed to increase the distance between the
legs until the participant indicated that the position was stable
enough to perform the task. Twenty-six participants were not
able to perform the task in semitandem stance and were thus
allowed to use parallel stance. During the task, participants wore
the DynaPort R© sensor (McRoberts, Netherlands) at the level of
the third and fourth lumbar spine segment, attached via an elastic
velcro belt.
MPF, area, acceleration, jerk, and velocity were extracted. MPF
is a measure for the frequency content of the signal given in Hz.
It can be seen as the body’s basic oscillation (Lamoth et al., 2009).
Area is a measure for a person’s needed area to maintain the body
along the gravitational vertical during balancing performance.
From the center of the stabilogramm, the distance to every data
point is determined. Afterward, a circle with a radius covering
90% of the largest distance is constructed that is the evaluated
area given in mm2. Acceleration describes the root mean square
(RMS) mean acceleration of the compensatory movements (mG),
and is presented in anteroposterior (AP) and mediolateral (ML)
direction. Jerk, the time derivate of acceleration, quantifies
smoothness of the compensatory movements. It is given in
mG/s. Smoothness is broadly regarded as a hallmark of skilled,
coordinated movement (Hogan and Sternad, 2009). Also jerk
is presented in AP and ML direction. Velocity describes the
mean velocity of the compensatory movements and is given
in mm/s. Also this parameter is presented in the AP and ML
direction.
SNP Analysis
The genotypes of the SNPs of the SLC5A7 (rs6542746), CHAT
(rs3810950), BCHE (rs1803274), and CHRNA4 gene (rs2236196)
were extracted from NeuroX array data, the dataset and
procedures are described in Nalls et al. (2014). Call rate was 100%
and HWE was >0.05. SNP locations and frequencies are listed in
Supplementary Table 1.
Statistical Analysis
Statistical analysis was performed with SPSS Statistics 22,
IBM. Demographic and clinical data are presented with mean
and standard deviation (SD). Quantitative postural control
parameters were checked for outliers, and values ≥3 STD from
the mean were excluded. Non-normally distributed parameters
were log transformed before analysis (area, acceleration ML
and jerk AP and ML). Comparisons of genotypes with postural
control parameters were performed with a linear regression
model, by including age, gender, Beck’s Depression Inventory
score and pallaesthesia as potential confounders in the model.
The effect of combining SNPs SLC5A7 rs6542746 and CHAT
rs3810950 was analyzed by scoring of the, respectively, rare
alleles. p-Values were considered trends toward significance when
0.0016 < p < 0.05, and significant when p ≤ 0.0016 (four SNPs,
eight postural control parameters). The reported effect sizes were
calculated according to Cohen’s f2 score (Cohen, 1988). Data are
shown in Supplementary Table 2.
RESULTS
The mean age of the cohort was 69 years, and 41.3% were women.
Table 1 provides demographic and clinical details.
SNP Association Analysis With Postural
Control Parameters
Details about significant results on both, a Bonferroni-corrected
and uncorrected level, are presented in Figures 2A,B. Individuals
carrying a genotype with the minor C allele in SLC5A7 rs6542746
showed lower MPF values (CC: 4.04/CT: 4.15/TT: 4.22 Hz,
p = 3.91 × 10−4, f 2 = 0.028), compared to the major T allele.
Acceleration AP values showed a strong dose-dependent trend
toward significance with higher minor allele representation (CC:
318/CT: 314/TT: 287 mG, p = 0.005, f 2 = 0.017).
Genotypes containing the minor A allele in CHAT rs3810950
showed dose-dependent higher values in acceleration ML [AA:
1.77/AG: 1.70/GG: 1.65 log(mG), p = 0.03, f 2 = 0.012], velocity
ML [AA: 1.83/AG: 1.78/GG: 1.74 log(mm/s), p = 0.019,
f 2 = 0.012], jerk AP [AA: 2.28/AG: 2.20/GG: 2.15 log(mG/s),
p = 0.048, f 2 = 0.009] and velocity AP [AA: 1.80/AG: 1.75/GG:
1.74 log(mm/s), p = 0.064, f 2 = 0.007] compared to the major G
allele.
Combination of SLC5A7 rs6542746 and
CHAT rs3810950
Individuals scored for the presence of the minor alleles of both
SNPs in SLC5A7 rs6542746 and in CHAT rs3810950 showed a
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FIGURE 1 | Overview of the study protocol. (A) Participants were asked to perform a difficult static balance task. During the assessment, they wore an inertial
measurement unit (DynaPort R©, McRoberts, Netherlands) at the lower back. (B) Acceleration signals were analyzed with validated algorithms provided by the
company. (C) Collection of blood for genetic analysis (D).
TABLE 1 | Means and standard deviations of relevant demographic and postural
control parameters of the included cohort.
Mean Standard deviation
N (females) 477 (197) –
Age (years) 69 6
BMI [weight/(height2)] 26 4
Height (cm) 171 9
BDI (0–63) 4 4
MMSE (0–30) 29 1
Pallesthesia (0–8) 7 2
MPF (Hz) 4.2 0.5
Area (mm2) 3.159 2.538
Acceleration AP (mG) 307 116
Acceleration ML (mG) 56 32
Jerk AP (mG/s) 280 455
Jerk ML (mG/s) 345 627
Velocity AP (mm/s) 64 35
Velocity ML (mm/s) 68 40
AP, anteroposterior; BDI, Beck’s Depression Inventory; BMI, body mass index; ML,
mediolateral; MMSE, Mini Mental Status Exam; MPF, mean power frequency.
dose-dependent lowering of MPF values (p = 0.004, f 2 = 0.018,
Figure 2C).
BCHE rs1803274 and CHRNA4 rs2236196 SNPs were not
significantly associated with any of the postural control
parameters (data not shown).
DISCUSSION
During the course of aging (Heuninckx et al., 2008) and
in neurological disorders such as PD (Helmich et al., 2007),
postural control deficits become increasingly common in the
5th decade of life and later (Schumacher et al., 2014) and have
a substantial influence on life quality of the affected (Maetzler
et al., 2013b). Recent findings demonstrate that compensated
postural control deficits, as they occur, e.g., during prodromal
phases of neurodegenerative diseases, become detectable when
this system is maximally challenged (Maetzler et al., 2012). Such
a challenge can be, e.g., standing in semitandem position on a
foam pad with eyes closed (Horak and Mancini, 2013). Based
on consistent results of several studies (Chung et al., 2010;
Karachi et al., 2010; Rochester et al., 2012; Muller et al., 2013)
indicating that the cholinergic system plays a central role in
postural control, genetic variation in the following four genes of
the cholinergic pathway, SLC5A7, CHAT, BCHE, and CHRNA4,
were examined in this study regarding their potential influence
on postural control parameters in healthy older adults. To our
best knowledge, this is the first report linking genetic variation in
the cholinergic system to quantitative changes in postural control
performance in a representative cohort of older adults. This
research issue is particularly interesting in the light of a recent
study (Richter et al., 2014), which suggests that ACHE activity
in the brain is individually and locally regulated and influences
specific cognitive tasks closely and specifically.
In this study, the SNP rs6542746 in the SLC5A7 gene
showed significant association with MPF and a strong trend
toward significance with acceleration AP. Although some
literature suggests that MPF increases with age, recent studies
indicate that patients with PD in clinical (Mancini et al.,
2012a) and even in their prodromal stages (Hasmann, 2015)
present with reduced MPF. The reasons for this reduction
of MPF in relation to neurodegenerative processes are not
understood, yet. Nevertheless, our results suggest that the
postural control assessment applied here has the potential
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FIGURE 2 | Main associations of SNPs of the cholinergic system with postural control parameters. (A) The SLC5A7 SNP was associated with changes of mean
power frequency (MPF) and acceleration in the anteroposterior (AP) direction. (B) The CHAT SNP was associated with changes of both velocity and acceleration in
the mediolateral (ML) direction. (C) Increasing presence of minor alleles of both SNPs, SLC5A7 and CHAT, was associated with decreasing MPF.
to detect subtle changes of the cholinergic system beyond
aging effects, and may reflect subtle changes due to, e.g.,
neurodegeneration. It is also possible that not an, e.g., age-
related, degeneration of the cholinergic system per se explains
our results (Ellis et al., 2009; Lotfipour et al., 2011) but
rather the degeneration of the dopaminergic system or the
occurrence/increase of white matter lesions (Richter et al., 2017)
unmask a constitutionally “weak” cholinergic system determined
by the cholinergic polymorphisms. These hypotheses have to
be evaluated with longitudinal observation studies, including
also the actual TREND cohort. The trend toward higher
acceleration AP in the minor allele of the SLC5A7 rs6542746
SNP also suggests worse postural control (Horak and Mancini,
2013).
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Increase of acceleration in AP direction may reflect a postural
control deficit that is different from an increase of acceleration
in ML direction. This aspect has been nicely demonstrated in
a previous experimental study (Runge et al., 1999). Eventually,
increases of both AP and ML accelerations may indicate a
prodromal phase of neurodegeneration (Maetzler et al., 2012).
The CHAT rs3810950 SNP showed strong trends toward
significance in acceleration ML and velocity ML. Both parameters
were higher in individuals carrying the minor allele, and showed
a linear dose dependency. Higher acceleration ML has previously
been demonstrated in high-risk individuals for PD (Maetzler
et al., 2012) and in clinically overt PD patients (Palmerini et al.,
2011), as well as in elderly individuals who are prone to falls
(Melzer et al., 2010; Merlo et al., 2012). All these previous
studies, in conjunction with our current results, give further
support for the proposed influence of the cholinergic system
on postural stability. Furthermore, our results suggest: (i) that
postural stability, at least in advanced age, is partly determined
by genetic predisposition, and (ii) that acceleration and velocity
parameters extracted from a challenging quiet standing task are
promising markers to describe such (subtle) postural control
deficits.
To test for a summation effect, the two above-mentioned SNPs
(rs6542746 and rs3810950) were compared simultaneously with
postural control parameters. The analysis showed a strong and
linear negative trend between number of overall minor alleles
and MPF value. In our view, this result also supports the idea
of a relevant influence of the cholinergic system on MPF and, in
line with this relevant influence, for a particularly high potential
of MPF to serve as a “window” into a better understanding of
the cholinergic system and its association with human postural
control.
The SNP rs1803274 in the BCHE gene and the SNP
rs2236196 in theCHRNA4 gene showed no statistically significant
associations to postural control parameters in our cohort of
healthy older adults. We included these gene variants in this
study, as our study was designed as an exploratory analysis
and it was intriguing to speculate that the respective gene
products could influence postural control due to their relevance
within the cholinergic system. However, direct evidence for this
hypothesis has not been published, yet, for neither of these
variants. Moreover, we investigated a different SNP in CHRNA4
(rs1044396) as mentioned in the literature, which is not in
strong linkage disequilibrium. This fact might explain the lack of
association of the actual SNP with postural control parameters.
This hypothesis has to be tested in future studies. Overall, the
influence of the two latter gene variants may be more relevant
for the cholinergic system associated with cognitive impairment.
The study faces the limitation that the number of people in
the respective genotype groups – except for the SNP in SLC5A7 –
varied greatly with on average 255 individuals being homozygous
for the major allele and about 30 individuals for the minor allele.
We may thus have overlooked existing influences of some genetic
variants due to lack of power. Moreover, with the experimental
approach presented here we cannot exclude that our results
may be explained -at least partly- by changes occurring at the
neuromuscular junction.
CONCLUSION
This pilot investigation provides novel information about the
association between genetic variants of the cholinergic system
and postural control parameters in older adults. Our results
should motivate further investigations with larger cohorts and
longitudinal study designs.
AUTHOR CONTRIBUTIONS
CA, CS, and WM conceptualized the study, analyzed the data,
and revised the manuscript. MM drafted the manuscript, was
involved in the analysis and interpretation of the data, and
provided substantial input to the revisions. US, LZ, FM, TG, GE,
A-KH, and DB were involved in data acquisition, and analysis of
raw data, and revised the manuscript.
FUNDING
FM received financial support from Storz medical AG. TG
receives third party funding from the Michael J. Fox Foundation,
the German Federal Ministry of Education and Research
(BMBF), the European Union and the Charitable Hertie-
Foundation. He has received speaker’s honoraria from UCB,
MedUpdate, Merck-Serono, TEVA and Novartis and holds
a patent concerning the LRRK2 gene and neurodegenerative
disorders. GE received funding from EU-Horizon 2020, BMBF
(NIVIL) and Innovationsfond des GBA (PAWEL). DB received
and receives funding from the Michael J. Fox Foundation, Janssen
Pharmaceutica N.V., German Parkinson’s Disease Association
(dPV), BMWi, BMBF, Parkinson Fonds Deutschland gGmbH,
UCB Pharma GmbH, TEVA Pharma GmbH, EU, Novartis
Pharma GmbH, Lundbeck. She received speaker honoraria from
UCB Pharma GmbH, Lundbeck, BIAL, and was invited to
Advisory Boards of UCB Pharma GmbH, Lundbeck, Prexton
Therapeutics, GE-Healthcare. WM received and receives funding
from the European Union, the Michael J. Fox Foundation, Robert
Bosch Foundation, Neuroalliance, Lundbeck and Janssen, and
holds part of a patent for the assessment of dyskinesias (German
patent office, 102015220741.2). He received speaker honoraria
from GlaxoSmithKline, Abbvie, UCB, Licher MT and Rölke
Pharma, and was invited to Advisory Boards of Market Access
& Pricing Strategy GmbH and Abbvie.
ACKNOWLEDGMENTS
We acknowledge financial support by Land Schleswig-Holstein
within the funding program Open Access Publikationsfonds.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fnagi.2018.
00260/full#supplementary-material
Frontiers in Aging Neuroscience | www.frontiersin.org 6 September 2018 | Volume 10 | Article 260
fnagi-10-00260 August 31, 2018 Time: 18:35 # 7
Arnold et al. Arnold: Cholinergic SNPs and Postural Control
REFERENCES
Adkin, A. L., Frank, J. S., and Jog, M. S. (2003). Fear of falling and postural control
in Parkinson’s disease. Mov. Disord. 18, 496–502. doi: 10.1002/mds.10396
Berg, K. O., Maki, B. E., Williams, J. I., Holliday, P. J., and Wood-Dauphinee,
S. L. (1992). Clinical and laboratory measures of postural balance in an elderly
population. Arch. Phys. Med. Rehabil. 73, 1073–1080.
Berry, A. S., Demeter, E., Sabhapathy, S., English, B. A., Blakely, R. D., Sarter, M.,
et al. (2014). Disposed to distraction: genetic variation in the cholinergic system
influences distractibility but not time-on-task effects. J. Cogn. Neurosci. 26,
1981–1991. doi: 10.1162/jocn_a_00607
Bohnen, N. I., Muller, M. L., Koeppe, R. A., Studenski, S. A., Kilbourn, M. A.,
Frey, K. A., et al. (2009). History of falls in Parkinson disease is associated
with reduced cholinergic activity. Neurology 73, 1670–1676. doi: 10.1212/WNL.
0b013e3181c1ded6
Chung, K. A., Lobb, B. M., Nutt, J. G., and Horak, F. B. (2010). Effects of a central
cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 75,
1263–1269. doi: 10.1212/WNL.0b013e3181f6128c
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd Edn.
Hillsdale, N.J: L. Erlbaum Associates.
Demura, S., and Kitabayashi, T. (2006). Comparison of power spectrum
characteristics of body sway during a static upright standing posture in healthy
elderly people and young adults. Percept. Mot. Skills 102, 467–476. doi: 10.2466/
pms.102.2.467-476
Deschamps, T., Beauchet, O., Annweiler, C., Cornu, C., and Mignardot, J. B. (2014).
Postural control and cognitive decline in older adults: position versus velocity
implicit motor strategy. Gait Posture. 39, 628–630. doi: 10.1016/j.gaitpost.2013.
07.001
Dewhurst, S., Riches, P. E., and De Vito, G. (2007). Moderate alterations in
lower limbs muscle temperature do not affect postural stability during quiet
standing in both young and older women. J. Electromyogr. Kinesiol. 17, 292–298.
doi: 10.1016/j.jelekin.2006.03.002
Eggert, M., Winterer, G., Wanischeck, M., Hoda, J. C., Bertrand, D., and
Steinlein, O. (2015). The nicotinic acetylcholine receptor alpha 4 subunit
contains a functionally relevant SNP Haplotype. BMC Genet. 16:46. doi: 10.
1186/s12863-015-0204-1
Ellis, J. R., Nathan, P. J., Villemagne, V. L., Mulligan, R. S., Ellis, K. A., Tochon-
Danguy, H. J., et al. (2009). The relationship between nicotinic receptors
and cognitive functioning in healthy aging: an in vivo positron emission
tomography (PET) study with 2-[(18)F]fluoro-A-85380. Synapse 63, 752–763.
doi: 10.1002/syn.20642
Era, P., Sainio, P., Koskinen, S., Haavisto, P., Vaara, M., and Aromaa, A. (2006).
Postural balance in a random sample of 7,979 subjects aged 30 years and over.
Gerontology 52, 204–213. doi: 10.1159/000093652
Frenklach, A., Louie, S., Koop, M. M., and Bronte-Stewart, H. (2009). Excessive
postural sway and the risk of falls at different stages of Parkinson’s disease. Mov.
Disord. 24, 377–385. doi: 10.1002/mds.22358
Greenwood, P. M., Parasuraman, R., and Espeseth, T. (2012). A cognitive
phenotype for a polymorphism in the nicotinic receptor gene CHRNA4.
Neurosci. Biobehav. Rev. 36, 1331–1341. doi: 10.1016/j.neubiorev.2012.02.010
Hasmann, S. E. (2015). Quantitative Tests des Statischen Gleichgewichts in der
Prodromalphase des Parkinson-syndroms. Doctoral Dissertation, Universität
Tübingen, Tübingen.
Healy, D. G., Falchi, M., O’Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., et al.
(2008). Phenotype, genotype, and worldwide genetic penetrance of LRRK2-
associated Parkinson’s disease: a case-control study. Lancet Neurol. 7, 583–590.
doi: 10.1016/S1474-4422(08)70117-0
Helmich, R. C., de Lange, F. P., Bloem, B. R., and Toni, I. (2007). Cerebral
compensation during motor imagery in Parkinson’s disease. Neuropsychologia
45, 2201–2215. doi: 10.1016/j.neuropsychologia.2007.02.024
Henderson, E. J., Lord, S. R., Brodie, M. A., Gaunt, D. M., Lawrence, A. D., Close,
J. C., et al. (2016). Rivastigmine for gait stability in patients with Parkinson’s
disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2
trial. Lancet Neurol. 15, 249–258. doi: 10.1016/S1474-4422(15)00389-0
Heuninckx, S., Wenderoth, N., and Swinnen, S. P. (2008). Systems neuroplasticity
in the aging brain: recruiting additional neural resources for successful
motor performance in elderly persons. J. Neurosci. 28, 91–99. doi: 10.1523/
JNEUROSCI.3300-07.2008
Hobert, M. A., Niebler, R., Meyer, S. I., Brockmann, K., Becker, C., Huber, H., et al.
(2011). Poor trail making test performance is directly associated with altered
dual task prioritization in the elderly–baseline results from the TREND study.
PLoS One 6:e27831. doi: 10.1371/journal.pone.0027831
Hogan, N., and Sternad, D. (2009). Sensitivity of smoothness measures to
movement duration, amplitude, and arrests. J. Mot. Behav. 41, 529–534.
doi: 10.3200/35-09-004-RC
Horak, F. B., and Mancini, M. (2013). Objective biomarkers of balance and gait
for Parkinson’s disease using body-worn sensors. Mov. Disord. 28, 1544–1551.
doi: 10.1002/mds.25684
Karachi, C., Grabli, D., Bernard, F. A., Tande, D., Wattiez, N., Belaid, H., et al.
(2010). Cholinergic mesencephalic neurons are involved in gait and postural
disorders in Parkinson disease. J. Clin. Invest. 120, 2745–2754. doi: 10.1172/
JCI42642
Kim, K. W., Suh, Y. J., Park, W. Y., Jhoo, J. H., Lee, D. Y., Youn, J. C., et al. (2004).
Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer’s
disease in concert with Apolipoprotein E epsilon4. Neurosci. Lett. 366, 182–186.
doi: 10.1016/j.neulet.2004.05.041
Kucinski, A., and Sarter, M. (2015). Modeling Parkinson’s disease falls associated
with brainstem cholinergic systems decline. Behav. Neurosci. 129, 96–104.
doi: 10.1037/bne0000048
Lamoth, C. J., van Lummel, R. C., and Beek, P. J. (2009). Athletic skill level
is reflected in body sway: a test case for accelometry in combination with
stochastic dynamics. Gait Posture 29, 546–551. doi: 10.1016/j.gaitpost.2008.
12.006
Lange, K. W., Wells, F. R., Jenner, P., and Marsden, C. D. (1993). Altered
muscarinic and nicotinic receptor densities in cortical and subcortical brain
regions in Parkinson’s disease. J. Neurochem. 60, 197–203. doi: 10.1111/j.1471-
4159.1993.tb05838.x
Lee, M. S., Rinne, J. O., and Marsden, C. D. (2000). The pedunculopontine nucleus:
its role in the genesis of movement disorders. Yonsei Med. J. 41, 167–184.
doi: 10.3349/ymj.2000.41.2.167
Lotfipour, S., Mandelkern, M., and Brody, A. L. (2011). Quantitative molecular
imaging of neuronal nicotinic acetylcholine receptors in the human brain
with A-85380 radiotracers. Curr. Med. Imaging Rev. 7, 107–112. doi: 10.2174/
157340511795445676
Maetzler, W., Domingos, J., Srulijes, K., Ferreira, J. J., and Bloem, B. R. (2013a).
Quantitative wearable sensors for objective assessment of Parkinson’s disease.
Mov. Disord. 28, 1628–1637. doi: 10.1002/mds.25628
Maetzler, W., Nieuwhof, F., Hasmann, S. E., and Bloem, B. R. (2013b). Emerging
therapies for gait disability and balance impairment: promises and pitfalls. Mov.
Disord. 28, 1576–1586. doi: 10.1002/mds.25682
Maetzler, W., Mancini, M., Liepelt-Scarfone, I., Muller, K., Becker, C., van Lummel,
R. C., et al. (2012). Impaired trunk stability in individuals at high risk
for Parkinson’s disease. PLoS One 7:e32240. doi: 10.1371/journal.pone.003
2240
Mancini, M., Carlson-Kuhta, P., Zampieri, C., Nutt, J. G., Chiari, L., and Horak,
F. B. (2012a). Postural sway as a marker of progression in Parkinson’s disease: a
pilot longitudinal study. Gait Posture 36, 471–476. doi: 10.1016/j.gaitpost.2012.
04.010
Mancini, M., Salarian, A., Carlson-Kuhta, P., Zampieri, C., King, L., Chiari, L.,
et al. (2012b). ISway: a sensitive, valid and reliable measure of postural control.
J. Neuroeng. Rehabil. 9, 59. doi: 10.1186/1743-0003-9-59
Mancini, M., Horak, F. B., Zampieri, C., Carlson-Kuhta, P., Nutt, J. G., and
Chiari, L. (2011). Trunk accelerometry reveals postural instability in untreated
Parkinson’s disease. Parkinsonism Relat. Disord. 17, 557–562. doi: 10.1016/j.
parkreldis.2011.05.010
Manckoundia, P., Mourey, F., Perennou, D., and Pfitzenmeyer, P. (2008). Backward
disequilibrium in elderly subjects. Clin. Interv. Aging 3, 667–672. doi: 10.2147/
CIA.S3811
Masani, K., Vette, A. H., Kouzaki, M., Kanehisa, H., Fukunaga, T., and Popovic,
M. R. (2007). Larger center of pressure minus center of gravity in the elderly
induces larger body acceleration during quiet standing. Neurosci. Lett. 422,
202–206. doi: 10.1016/j.neulet.2007.06.019
McVey, M. A., Stylianou, A. P., Luchies, C. W., Lyons, K. E., Pahwa, R.,
Jernigan, S., et al. (2009). Early biomechanical markers of postural instability
in Parkinson’s disease. Gait Posture 30, 538–542. doi: 10.1016/j.gaitpost.2009.
08.232
Frontiers in Aging Neuroscience | www.frontiersin.org 7 September 2018 | Volume 10 | Article 260
fnagi-10-00260 August 31, 2018 Time: 18:35 # 8
Arnold et al. Arnold: Cholinergic SNPs and Postural Control
Melzer, I., Kurz, I., and Oddsson, L. I. (2010). A retrospective analysis of balance
control parameters in elderly fallers and non-fallers. Clin. Biomech. 25, 984–988.
doi: 10.1016/j.clinbiomech.2010.07.007
Merlo, A., Zemp, D., Zanda, E., Rocchi, S., Meroni, F., Tettamanti, M., et al. (2012).
Postural stability and history of falls in cognitively able older adults: the Canton
Ticino study. Gait Posture 36, 662–666. doi: 10.1016/j.gaitpost.2012.06.016
Michalowska, M., Fiszer, U., Krygowska-Wajs, A., and Owczarek, K. (2005). Falls in
Parkinson’s disease. Causes and impact on patients’ quality of life. Funct. Neurol.
20, 163–168.
Muller, M. L., Albin, R. L., Kotagal, V., Koeppe, R. A., Scott, P. J., Frey, K. A.,
et al. (2013). Thalamic cholinergic innervation and postural sensory integration
function in Parkinson’s disease. Brain 136(Pt 11), 3282–3289. doi: 10.1093/
brain/awt247
Nalls, M. A., Pankratz, N., Lill, C. M., Do, C. B., Hernandez, D. G., Saad, M., et al.
(2014). Large-scale meta-analysis of genome-wide association data identifies six
new risk loci for Parkinson’s disease. Nat. Genet. 46, 989–993. doi: 10.1038/ng.
3043
Oude Nijhuis, L. B., Allum, J. H., Nanhoe-Mahabier, W., and Bloem, B. R. (2014).
Influence of perturbation velocity on balance control in Parkinson’s disease.
PLoS One 9:e86650. doi: 10.1371/journal.pone.0086650
Ozturk, A., DeKosky, S. T., and Kamboh, M. I. (2006). Genetic variation
in the choline acetyltransferase (CHAT) gene may be associated with the
risk of Alzheimer’s disease. Neurobiol. Aging 27, 1440–1444. doi: 10.1016/j.
neurobiolaging.2005.08.024
Pahapill, P. A., and Lozano, A. M. (2000). The pedunculopontine nucleus and
Parkinson’s disease. Brain 123(Pt 9), 1767–1783. doi: 10.1093/brain/123.9.1767
Palmerini, L., Rocchi, L., Mellone, S., Valzania, F., and Chiari, L. (2011). Feature
selection for accelerometer-based posture analysis in Parkinson’s disease. IEEE
Trans. Inf. Technol. Biomed. 15, 481–490. doi: 10.1109/TITB.2011.2107916
Park, J. H., Mancini, M., Carlson-Kuhta, P., Nutt, J. G., and Horak, F. B.
(2016). Quantifying effects of age on balance and gait with inertial sensors in
community-dwelling healthy adults. Exp. Gerontol. 85, 48–58. doi: 10.1016/j.
exger.2016.09.018
Podoly, E., Shalev, D. E., Shenhar-Tsarfaty, S., Bennett, E. R., Ben Assayag, E.,
Wilgus, H., et al. (2009). The butyrylcholinesterase K variant confers
structurally derived risks for Alzheimer pathology. J. Biol. Chem. 284,
17170–17179. doi: 10.1074/jbc.M109.004952
Reinvang, I., Lundervold, A. J., Rootwelt, H., Wehling, E., and Espeseth, T.
(2009). Individual variation in a cholinergic receptor gene modulates attention.
Neurosci. Lett. 453, 131–134. doi: 10.1016/j.neulet.2009.02.029
Reinvang, I., Lundervold, A. J., Wehling, E., Rootwelt, H., and Espeseth, T.
(2010). Epistasis between APOE and nicotinic receptor gene CHRNA4 in age
related cognitive function and decline. J. Int. Neuropsychol. Soc. 16, 424–432.
doi: 10.1017/S1355617710000263
Richter, N., Allendorf, I., Onur, O. A., Kracht, L., Dietlein, M., Tittgemeyer, M.,
et al. (2014). The integrity of the cholinergic system determines memory
performance in healthy elderly. Neuroimage 100, 481–488. doi: 10.1016/j.
neuroimage.2014.06.031
Richter, N., Michel, A., Onur, O. A., Kracht, L., Dietlein, M., Tittgemeyer, M.,
et al. (2017). White matter lesions and the cholinergic deficit in aging
and mild cognitive impairment. Neurobiol. Aging 53, 27–35. doi: 10.1016/j.
neurobiolaging.2017.01.012
Rocchi, L., Chiari, L., and Cappello, A. (2004). Feature selection of stabilometric
parameters based on principal component analysis. Med. Biol. Eng. Comput. 42,
71–79. doi: 10.1007/BF02351013
Rochester, L., Yarnall, A. J., Baker, M. R., David, R. V., Lord, S., Galna, B.,
et al. (2012). Cholinergic dysfunction contributes to gait disturbance in
early Parkinson’s disease. Brain 135(Pt 9), 2779–2788. doi: 10.1093/brain/
aws207
Ruberg, M., Ploska, A., Javoy-Agid, F., and Agid, Y. (1982). Muscarinic binding
and choline acetyltransferase activity in Parkinsonian subjects with reference to
dementia. Brain Res. 232, 129–139. doi: 10.1016/0006-8993(82)90615-1
Runge, C. F., Shupert, C. L., Horak, F. B., and Zajac, F. E. (1999). Ankle and
hip postural strategies defined by joint torques. Gait Posture 10, 161–170. doi:
10.1016/S0966-6362(99)00032-6
Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2014).
Biological insights from 108 schizophrenia-associated genetic loci. Nature 511,
421–427. doi: 10.1038/nature13595
Schumacher, J., Pientka, L., Trampisch, U., Moschny, A., Hinrichs, T., and
Thiem, U. (2014). The prevalence of falls in adults aged 40 years or older in
an urban, German population. Results from a telephone survey. Z. Gerontol.
Geriatr. 47, 141–146. doi: 10.1007/s00391-013-0503-y
Sciadas, R., Dalton, C., and Nantel, J. (2016). Effort to reduce postural sway affects
both cognitive and motor performances in individuals with Parkinson’s disease.
HumMov Sci. 47, 135–140. doi: 10.1016/j.humov.2016.03.003
Tinetti, M. E., and Williams, C. S. (1997). Falls, injuries due to falls, and
the risk of admission to a nursing home. N Engl. J. Med. 337, 1279–1284.
doi: 10.1056/NEJM199710303371806
Tsai, S. J., Yeh, H. L., Hong, C. J., Liou, Y. J., Yang, A. C., Liu, M. E., et al.
(2012). Association of CHRNA4 polymorphism with depression and loneliness
in elderly males. Genes Brain Behav. 11, 230–234. doi: 10.1111/j.1601-183X.
2011.00741.x
Van Ooteghem, K., Frank, J. S., and Horak, F. B. (2009). Practice-related
improvements in posture control differ between young and older adults exposed
to continuous, variable amplitude oscillations of the support surface. Exp. Brain
Res. 199, 185–193. doi: 10.1007/s00221-009-1995-y
Woollacott, M. H. (2000). Systems contributing to balance disorders in older
adults. J. Gerontol. A Biol. Sci. Med. Sci. 55, M424–M428. doi: 10.1093/gerona/
55.8.M424
Yarnall, A., Rochester, L., and Burn, D. J. (2011). The interplay of cholinergic
function, attention, and falls in Parkinson’s disease.Mov. Disord. 26, 2496–2503.
doi: 10.1002/mds.23932
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Arnold, Schulte, Moscovich, Sünkel, Zaunbrecher, Metzger, Gasser,
Eschweiler, Hauser, Berg and Maetzler. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 8 September 2018 | Volume 10 | Article 260
